Results 261 to 270 of about 900,970 (340)

Ancient DNA connects large-scale migration with the spread of Slavs. [PDF]

Nature
Gretzinger J, Biermann F, Mager H, King B, Zlámalová D, Traverso L, Gnecchi Ruscone GA, Peltola S, Salmela E, Neumann GU, Radzeviciute R, Ingrová P, Liwoch R, Wronka I, Jurić R, Hyrchała A, Niezabitowska-Wiśniewska B, Bartecki B, Borowska B, Dzieńkowski T, Wołoszyn M, Wojenka M, Wilczyński J, Kot M, Müller E, Orschiedt J, Zariņa G, Onkamo P, Daim F, Muhl A, Schwarz R, Majer M, McCormick M, Květina J, Vida T, Geary PJ, Macháček J, Šlaus M, Meller H, Pohl W, Hofmanová Z, Krause J.   +41 more
europepmc   +1 more source

Global burden and cross-country inequalities of alcoholic cardiomyopathy: A 1990-2021 analysis. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Zheng M, Sun C, Li M, Xiang H, Ren H, Cheng J.   +5 more
europepmc   +1 more source

Real‐world efficacy and toxicity of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma according to IMDC risk criteria—A multi‐center retrospective analysis on behalf of the GUARDIANS group

International Journal of Cancer, EarlyView.
What's New? The combination of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma has demonstrated durable response and tolerability in clinical trials. However, inclusion criteria for clinical studies are restrictive, and patients in the real‐world setting tend to have more comorbidities.
Hendrik Dinkel, Linus Materna, Ramona Stelmach, Stefanie Zschäbitz, Stephanie Neuberger, Can D. Aydogdu, Jozefina Casuscelli, Timo Egenolf, Matteo Silberg, Julie Steinestel, Arne Strauss, Florian Kirchhoff, Marit Ahrens, Pia Paffenholz, Richard Cathomas, Berna C. Özdemir, Christopher Gossler, Philipp Ivanyi, Marc Rehlinghaus, Thomas Hilser, Viktor Grünwald, Katrin Schlack   +21 more
wiley   +1 more source

Global Patterns and Temporal Trends in Ovarian and Uterine Cancer Mortality Attributable to High Body-Mass Index, 1990-2023. [PDF]

Cancers (Basel)
Ilic I, Jakovljevic V, Lazic S, Ilic M.
europepmc   +1 more source

Treatment landscape from first‐ to third‐line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF‐PARAGON study)

International Journal of Cancer, EarlyView.
What's New? Pancreatic cancer often is diagnosed at advanced stages. As a result, treatment regimens frequently are aggressive, with substantial side effects that impact quality of life (QoL). This study examined the treatment landscape, from neoadjuvant therapy to palliative care, in the context of QoL among pancreatic cancer patients in Germany. Most
Thorsten O. Goetze, Salah‐Eddin Al‐Batran, Ruediger Liersch, Lars Scheuer, Thomas Goehler, Ulrich Kaiser, Claudio Denzlinger, Stephan Brandl, Daniel Pink, Jens Uhlig, Michael Maasberg, Maria Loose, Marina Schaaf, Disorn Sookthai, Bianca Zäpf, Claudia Pauligk, Timursah Habibzade, Ralf‐Dieter Hofheinz, Christine Koch, for the AIO Study Group   +19 more
wiley   +1 more source

Phylogenetics and evolution of Digitaria grasses, including cereal crops fonio, raishan and Polish millet. [PDF]

Ann Bot
Burton GP, Ceci P, MacKinnon L, Masters LE, Randrianarimanana NFH, Ryan P, Turnbull CGN, Ulian T, Vorontsova MS.   +8 more
europepmc   +1 more source

Emerging Parliaments between Corporative Representation and Interaction with the Royal Courts: Parliamentary History in Late Medieval and Early Modern Central Eastern Europe

Ulrike Müßig
openalex   +2 more sources

Patient‐ and caregiver‐reported barriers to chemotherapy in nine sub‐Saharan African countries: A cross‐sectional survey among population‐based registries

International Journal of Cancer, EarlyView.
What's New? Increasing cancer incidence and mortality in low‐ and middle‐income countries has heightened concerns about limited resources and barriers to care. This challenge is particularly urgent in Sub‐Saharan Africa (SSA), where cancer rates are rising sharply. Here, data from population‐based cancer registries in nine SSA countries was assessed to
Tamara König, Nikolaus Christian Simon Mezger, Ole Stoeter, Phoebe Mary Amulen, Margaret Borok, Gladys C. Chesumbai, Moudiongui MBoungou Dimitry, Ima‐Obong Ekanem, Adugna Fekadu, Bakarou Kamaté, William Muller, Alex Alain Kabena Nzambikolo, Abidemi Omonisi, Furaha Serventi, Markus Wallwiener, Biying Liu, Donald Maxwell Parkin, Pablo Sandro Carvalho Santos, Eva Johanna Kantelhardt, Eric Sven Kroeber   +19 more
wiley   +1 more source

Quaternary History of Deciduous Forests of Eastern North America and Europe

, 1983
Margaret B. Davis
openalex   +2 more sources

Immunotherapy in advanced gastroesophageal cancers: A meta‐analysis of sex‐based outcomes in overall survival

International Journal of Cancer, EarlyView.
What's New? Immune checkpoint inhibitors (ICIs) improve survival in advanced gastroesophageal cancer (GEC), but their benefits may differ by sex. Little is known, however about the impact of sex‐related immune differences on ICI efficacy. In this meta‐analysis, sex‐specific outcomes of ICI therapy were evaluated in advanced GEC, encompassing both ...
Michael Masetti, Fausto Petrelli, Filippo Pietrantonio, Sylvie Lorenzen, Alberto Giovanni Leone   +4 more
wiley   +1 more source